Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Prolonga Pharmaceuticals Denmark A/S
A/S
Bankrupt
Reklamebeskyttelse
CVR 39740192
Rådhuspladsen 16, 1550
København V
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2018 · 7 years old
— employees
Overvåg
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
Prolonga Pharmaceuticals Denmark A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Former (2)
PM
Piya Mukherjee
Unofficial title
Unofficial title
2020 – 2020
GM
Gert Mads Bolwig
Management
Management
2018 – 2020
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Former (2)
CY
Claus Yding Andersen
Board of Directors
Board of Directors
2018 – 2020
CR
Christopher Robin Axelsson
Chairman
Chairman
2018 – 2020
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Prolonga Pharmaceuticals Pte. Ltd.
Individual
100%
100%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Prolonga Pharmaceuticals Denmark A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
